Monopar Therapeutics, Inc. (MNPR)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$117.56-0.84%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · MNPR
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||
| Revenues | — | 0.0 | 0.0 | — | — | — | — | 0.0 | 0.0 | 0.0 |
| Total Revenues | — | 0.0 | 0.0 | — | — | — | — | 0.0 | 0.0 | 0.0 |
| Operating Expenses & Income | ||||||||||
| R&D Expenses | 14.8 | 9.9 | 13.0 | 5.6 | 7.6 | 6.5 | 4.1 | 2.0 | 1.8 | 0.9 |
| Operating Income | (22.1) | (16.7) | (16.2) | (8.8) | (10.5) | (9.1) | (6.5) | (4.3) | (3.3) | (16.6) |
| Earnings from Continuing Operations | ||||||||||
| Interest & Investment Income | 4.2 | 3.0 | 0.4 | 0.4 | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | — | (13.7) | (15.6) | (8.4) | — | — | — | — | (3.3) | — |
| Income Tax Expense | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | (0.1) | (0.0) |
| Net Income | ||||||||||
| Net Income | (17.8) | (13.7) | (15.6) | (8.4) | (10.5) | (9.1) | (6.3) | (4.2) | (3.2) | (16.6) |
| Per Share | ||||||||||
| Basic EPS | (2.09) | (1.85) | (4.11) | (3.04) | (0.83) | — | — | — | — | — |
| Basic Weighted Avg Shares | 8.5 | 7.4 | 3.8 | 2.8 | 12.7 | 12.5 | — | — | — | — |
| Supplemental | ||||||||||
| EBIT | (22.1) | (16.7) | (16.2) | (8.8) | (10.5) | (9.1) | (6.5) | (4.3) | (3.3) | (16.6) |
| Effective Tax Rate | — | — | — | -0.0% | — | — | — | — | 2.1% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.